# Legacy Pharmaceuticals Switzerland GmbH – FDA Inspection, Jul 21, 2017

Source: https://www.keypedia.com/records/fda_inspections/legacy-pharmaceuticals-switzerland-gmbh/d687ff6c-8625-4830-98d4-e5a2f1f54816
Source feed: FDA_Inspections

> FDA inspection 1018900 of Legacy Pharmaceuticals Switzerland GmbH, July 21, 2017. Classification: Voluntary Action Indicated (VAI). 6 citations under 21 CFR part 211. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1018900
- Company Name: Legacy Pharmaceuticals Switzerland GmbH
- Inspection Date: 2017-07-21
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 6

## Related Documents

- FDA Inspection 661172 - 2010-03-30

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/michael-a-charles/f83241f0-ae3b-4535-ac03-e790bbf666ca)

Company: https://www.keypedia.com/companies/legacy-pharmaceuticals-switzerland-gmbh/12fbec96-87c8-4cc5-9c5d-f13acd0766f8

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c